Affimed N.V.
Market Cap
$1.54K
P/E Ratio
—
EPS
$-0.66
Dividend Yield
0.00%
52-Week Range
$0.00 — $10.91
Volume
138
Avg Volume
722
Beta
0.84
Get alerted when 0HL9.L hits your target price.
Free — enter your email to get started
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.00
P/S (TTM)
0.00
P/B (TTM)
0.00
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-1.01%
ROA (TTM)
-1.09%
ROIC
—
Gross Margin
1.00%
Operating Margin
-12.89%
Net Margin
—
Debt/Equity
0.33
Current Ratio
3.25
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.13%
EPS Growth (5Y)
-0.19%
Sales Growth (3Y)
-0.12%
Sales Growth (5Y)
-0.03%
EPS Est (This Year)
$-1.86
EPS Est (Next Year)
$-1.62
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$4.88
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
15.40M
Float
15.48M
Free Float %
100.49%
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
DE
Exchange
LSE
IPO Date
2018-02-13
Employees
76
CEO
Wolfgang Fischer
Index Membership
—
Website
https://www.affimed.com
Affimed N.V. (0HL9.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $1.54K, 0HL9.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0HL9.L against other stocks using dozens of fundamental and technical filters.
No, Affimed N.V. (0HL9.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Affimed N.V. (0HL9.L) has a market capitalization of $1,540, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.